|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Net premiums earned | |||||
| Net investment income | |||||
| Net realized gains on investments | |||||
| Fee income | |||||
| Other income | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Loss and loss adjustment expenses | |||||
| Sales and marketing | |||||
| Other insurance expense | |||||
| Technology and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Interest expense | |||||
| Loss on extinguishment of debt | |||||
| Income (loss) before income tax expense | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Changes in net unrealized gains on investments | |||||
| Comprehensive income (loss) | |||||
| Earnings (loss) per common share: (both Class A and B) | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding: (both Class A and B) | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Net income attributable to participating securities | |||||
| Net income (loss) attributable to common shareholders |
Loading...